Stockreport

Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? [Yahoo! Finance]

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF no-cost ExomeDx testing to eligible U.S. patients and contributing de-identified results to its GeneDx Infinity rare disease dataset. This collaboration highlights how [Read more]